S100A4 and colorectal carcinoma: Niclosamide represses transcription of S100A4 by inhibiting β-catenin expression and its binding to TCF (T-cell factor) which results in reduced migration of cells and lower metastasis burden in mice with colorectal carcinoma [18,21].